(VRSK) Verisk Analytics - Overview
Sector: Industrials | Industry: Consulting Services | Exchange: NASDAQ (USA) | Market Cap: 22.419m USD | Total Return: -43.9% in 12m
Avg Turnover: 297M
EPS Trend: 99.0%
Qual. Beats: 2
Rev. Trend: 89.5%
Qual. Beats: 2
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Verisk Analytics, Inc. (VRSK) is a global data analytics and technology provider specializing in the insurance sector. The company delivers solutions across the entire insurance value chain, including underwriting, risk selection, catastrophe modeling, and claims processing. Its platform serves property and casualty, life, and specialty insurance markets by integrating policy language, loss cost data, and anti-fraud tools into industry workflows.
Operating primarily as a vertical software and data provider, Verisk benefits from deep integration into the actuarial processes of its clients. The insurance data sector is characterized by high barriers to entry due to the proprietary nature of historical loss data and the regulatory requirements surrounding policy forms and rating rules. This business model typically generates recurring revenue through long-term subscriptions and licensed data access.
Investors can evaluate these competitive advantages and long-term valuation metrics further on ValueRay.
Founded in 1971 and headquartered in Jersey City, New Jersey, Verisk has expanded its international footprint to provide localized underwriting and claims solutions. Its technology suite includes property estimation tools for reconstruction and casualty solutions focused on compliance and workflow automation for the personal injury and motor franchises.
- Subscription revenue growth from property and casualty insurance underwriting data
- Increased frequency of natural disasters driving demand for catastrophe modeling tools
- Expansion of international market share through strategic claims technology acquisitions
- Operational margin expansion resulting from the divestiture of non-core business segments
- Regulatory changes in insurance rating rules impacting proprietary data solution pricing
| Net Income: 910.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.25 > 0.02 and ΔFCF/TA 5.27 > 1.0 |
| NWC/Revenue: 0.68% < 20% (prev 12.76%; Δ -12.08% < -1%) |
| CFO/TA 0.30 > 3% & CFO 1.38b > Net Income 910.2m |
| Net Debt (4.27b) to EBITDA (1.71b): 2.50 < 3 |
| Current Ratio: 1.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (135.2m) vs 12m ago -4.06% < -2% |
| Gross Margin: 67.44% > 18% (prev 0.69%; Δ 6.67k% > 0.5%) |
| Asset Turnover: 63.83% > 50% (prev 57.22%; Δ 6.61% > 0%) |
| Interest Coverage Ratio: 7.87 > 6 (EBITDA TTM 1.71b / Interest Expense TTM 177.8m) |
| A: 0.00 (Total Current Assets 1.20b - Total Current Liabilities 1.18b) / Total Assets 4.60b |
| B: 1.74 (Retained Earnings 7.98b / Total Assets 4.60b) |
| C: 0.29 (EBIT TTM 1.40b / Avg Total Assets 4.86b) |
| D: 1.40 (Book Value of Equity 8.07b / Total Liabilities 5.77b) |
| Altman-Z'' = 9.09 = AAA |
| DSRI: 0.93 (Receivables 554.3m/564.4m, Revenue 3.10b/2.93b) |
| GMI: 1.03 (GM 67.44% / 69.15%) |
| AQI: 1.15 (AQ_t 0.58 / AQ_t-1 0.51) |
| SGI: 1.06 (Revenue 3.10b / 2.93b) |
| TATA: -0.10 (NI 910.2m - CFO 1.38b) / TA 4.60b) |
| Beneish M = -3.04 (Cap -4..+1) = AA |
As of May 30, 2026, the stock is trading at USD 174.99 with a total of 2,238,463 shares traded.
Over the past week, the price has changed by +1.98%,
over one month by -7.01%,
over three months by -15.48% and
over the past year by -43.89%.
Verisk Analytics has received a consensus analysts rating of 3.39. Therefore, it is recommended to hold VRSK.
- StrongBuy: 3
- Buy: 3
- Hold: 10
- Sell: 2
- StrongSell: 0
| Analysts Target Price | 220.5 | 26% |
P/E Trailing = 26.1237
P/E Forward = 22.4215
P/S = 7.2266
P/B = 74.895
P/EG = 1.6595
Revenue TTM = 3.10b USD
EBIT TTM = 1.40b USD
EBITDA TTM = 1.71b USD
Long Term Debt = 4.20b USD (from longTermDebt, last quarter)
Short Term Debt = 283.3m USD (from shortTermDebt, last quarter)
Debt = 4.80b USD (from shortLongTermDebtTotal, last quarter) + Leases 170.7m
Net Debt = 4.27b USD (calculated: Debt 4.80b - CCE 525.2m)
Enterprise Value = 26.7b USD (22.4b + Debt 4.80b - CCE 525.2m)
Interest Coverage Ratio = 7.87 (Ebit TTM 1.40b / Interest Expense TTM 177.8m)
EV/FCF = 23.68x (Enterprise Value 26.7b / FCF TTM 1.13b)
FCF Yield = 4.22% (FCF TTM 1.13b / Enterprise Value 26.7b)
FCF Margin = 36.34% (FCF TTM 1.13b / Revenue TTM 3.10b)
Net Margin = 29.34% (Net Income TTM 910.2m / Revenue TTM 3.10b)
Gross Margin = 67.44% ((Revenue TTM 3.10b - Cost of Revenue TTM 1.01b) / Revenue TTM)
Gross Margin QoQ = 69.77% (prev 59.60%)
Tobins Q-Ratio = 5.80 (Enterprise Value 26.7b / Total Assets 4.60b)
Interest Expense / Debt = 3.71% (Interest Expense 177.8m / Debt 4.80b)
Taxrate = 24.08% (74.3m / 308.5m)
NOPAT = 1.06b (EBIT 1.40b * (1 - 24.08%))
Current Ratio = 1.02 (Total Current Assets 1.20b / Total Current Liabilities 1.18b)
Debt / Equity = -4.11 (negative equity) (Debt 4.80b / totalStockholderEquity, last quarter -1.17b)
Debt / EBITDA = 2.50 (Net Debt 4.27b / EBITDA 1.71b)
Debt / FCF = 3.79 (Net Debt 4.27b / FCF TTM 1.13b)
Total Stockholder Equity = -42.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 18.73% (Net Income 910.2m / Total Assets 4.60b)
RoE = -2.14k% (out of range, set to none) (Net Income TTM 910.2m / Total Stockholder Equity -42.6m)
RoCE = 33.62% (EBIT 1.40b / Capital Employed (Equity -42.6m + L.T.Debt 4.20b))
RoIC = 28.70% (NOPAT 1.06b / Invested Capital 3.70b)
WACC = 5.15% (E(22.4b)/V(27.2b) * Re(5.65%) + D(4.80b)/V(27.2b) * Rd(3.71%) * (1-Tc(0.24)))
Discount Rate = 5.65% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -100.00 | Cagr: -3.17%
[DCF] Terminal Value 77.87% ; FCFF base≈1.07b ; Y1≈1.22b ; Y5≈1.77b
[DCF] Fair Price = 171.2 (EV 26.7b - Net Debt 4.27b = Equity 22.4b / Shares 131.0m; r=8.35% [WACC [floored]]; 5y FCF grow 14.38% → 2.50% )
EPS Correlation: 99.05 | EPS CAGR: 9.82% | SUE: 1.18 | # QB: 2
Revenue Correlation: 89.52 | Revenue CAGR: 12.30% | SUE: 2.05 | # QB: 2
EPS current Quarter (2026-06-30): EPS=1.93 | Chg30d=-1.07% | Revisions=-20% | Analysts=16
EPS next Quarter (2026-09-30): EPS=1.95 | Chg30d=-0.58% | Revisions=-25% | Analysts=16
EPS current Year (2026-12-31): EPS=7.65 | Chg30d=+0.43% | Revisions=+40% | GrowthEPS=+6.8% | GrowthRev=+4.8%
EPS next Year (2027-12-31): EPS=8.66 | Chg30d=+0.71% | Revisions=+50% | GrowthEPS=+13.2% | GrowthRev=+6.8%
[Analyst] Revisions Ratio: +50%